Literature DB >> 34379499

Role of the Chaperone Protein 14-3-3ε in the Regulation of Influenza A Virus-Activated Beta Interferon.

Ee-Hong Tam1, Yen-Chin Liu2, Chian-Huey Woung3, Helene Minyi Liu4, Guan-Hong Wu1, Chih-Ching Wu1,2,3,5, Rei-Lin Kuo1,2,3,6.   

Abstract

The NS1 protein of the influenza A virus plays a critical role in regulating several biological processes in cells, including the type I interferon (IFN) response. We previously profiled the cellular factors that interact with the NS1 protein of influenza A virus and found that the NS1 protein interacts with proteins involved in RNA splicing/processing, cell cycle regulation, and protein targeting processes, including 14-3-3ε. Since 14-3-3ε plays an important role in retinoic acid-inducible gene I (RIG-I) translocation to mitochondrial antiviral-signaling protein (MAVS) to activate type I IFN expression, the interaction of the NS1 and 14-3-3ε proteins may prevent the RIG-I-mediated IFN response. In this study, we confirmed that the 14-3-3ε protein interacts with the N-terminal domain of the NS1 protein and that the NS1 protein inhibits RIG-I-mediated IFN-β promoter activation in 14-3-3ε-overexpressing cells. In addition, our results showed that knocking down 14-3-3ε can reduce IFN-β expression elicited by influenza A virus and enhance viral replication. Furthermore, we found that threonine in the 49th amino acid position of the NS1 protein plays a role in the interaction with 14-3-3ε. Influenza A virus expressing C terminus-truncated NS1 with a T49A mutation dramatically increases IFN-β mRNA in infected cells and causes slower replication than that of virus without the T-to-A mutation. Collectively, this study demonstrates that 14-3-3ε is involved in influenza A virus-initiated IFN-β expression and that the interaction of the NS1 protein and 14-3-3ε may be one of the mechanisms for inhibiting type I IFN activation during influenza A virus infection. IMPORTANCE Influenza A virus is an important human pathogen causing severe respiratory disease. The virus has evolved several strategies to dysregulate the innate immune response and facilitate its replication. We demonstrate that the NS1 protein of influenza A virus interacts with the cellular chaperone protein 14-3-3ε, which plays a critical role in retinoic acid-inducible gene I (RIG-I) translocation that induces type I interferon (IFN) expression, and that NS1 protein prevents RIG-I translocation to the mitochondrial membrane. The interaction site for 14-3-3ε is the RNA-binding domain (RBD) of the NS1 protein. Therefore, this research elucidates a novel mechanism by which the NS1 RBD mediates IFN-β suppression to facilitate influenza A viral replication. Additionally, the findings reveal the antiviral role of 14-3-3ε during influenza A virus infection.

Entities:  

Keywords:  14-3-3ε protein; NS1 protein; influenza A virus; interferon β

Mesh:

Substances:

Year:  2021        PMID: 34379499      PMCID: PMC8475545          DOI: 10.1128/JVI.00231-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production.

Authors:  J M Emeny; M J Morgan
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

Review 2.  The role of the 14-3-3 protein family in health, disease, and drug development.

Authors:  Yasaman Aghazadeh; Vassilios Papadopoulos
Journal:  Drug Discov Today       Date:  2015-10-09       Impact factor: 7.851

Review 3.  Structural basis of 14-3-3 protein functions.

Authors:  Tomas Obsil; Veronika Obsilova
Journal:  Semin Cell Dev Biol       Date:  2011-09-06       Impact factor: 7.727

4.  Activation of the 43 kDa inositol polyphosphate 5-phosphatase by 14-3-3zeta.

Authors:  J K Campbell; R Gurung; S Romero; C J Speed; R K Andrews; M C Berndt; C A Mitchell
Journal:  Biochemistry       Date:  1997-12-09       Impact factor: 3.162

5.  Global, quantitative and dynamic mapping of protein subcellular localization.

Authors:  Daniel N Itzhak; Stefka Tyanova; Jürgen Cox; Georg Hh Borner
Journal:  Elife       Date:  2016-06-09       Impact factor: 8.140

6.  Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery.

Authors:  Z Chen; Y Li; R M Krug
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

7.  Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I.

Authors:  Michaela Ulrike Gack; Randy Allen Albrecht; Tomohiko Urano; Kyung-Soo Inn; I-Chueh Huang; Elena Carnero; Michael Farzan; Satoshi Inoue; Jae Ung Jung; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2009-05-08       Impact factor: 21.023

8.  TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.

Authors:  Michaela U Gack; Young C Shin; Chul-Hyun Joo; Tomohiko Urano; Chengyu Liang; Lijun Sun; Osamu Takeuchi; Shizuo Akira; Zhijian Chen; Satoshi Inoue; Jae U Jung
Journal:  Nature       Date:  2007-04-19       Impact factor: 49.962

9.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs.

Authors:  M E Nemeroff; S M Barabino; Y Li; W Keller; R M Krug
Journal:  Mol Cell       Date:  1998-06       Impact factor: 17.970

10.  A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity.

Authors:  Ying Kai Chan; Michaela U Gack
Journal:  Nat Immunol       Date:  2016-03-21       Impact factor: 25.606

View more
  2 in total

1.  Signaling from the RNA sensor RIG-I is regulated by ufmylation.

Authors:  Daltry L Snider; Moonhee Park; Kristen A Murphy; Dia C Beachboard; Stacy M Horner
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-08       Impact factor: 12.779

2.  Interactome Profiling of N-Terminus-Truncated NS1 Protein of Influenza A Virus Reveals Role of 14-3-3γ in Virus Replication.

Authors:  Rei-Lin Kuo; Ee-Hong Tam; Chian-Huey Woung; Chu-Mi Hung; Hao-Ping Liu; Helene Minyi Liu; Chih-Ching Wu
Journal:  Pathogens       Date:  2022-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.